查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1722788

非處方藥 (OTC) 市場規模、佔有率、趨勢及預測（按產品類型、給藥途徑、劑型、配銷通路和地區），2025 年至 2033 年

Over The Counter (OTC) Drugs Market Size, Share, Trends and Forecast by Product Type, Route of Administration, Dosage Form, Distribution Channel, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球非處方藥 (OTC) 市場規模價值 1,780 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 2,882.9 億美元，2025 年至 2033 年的複合年成長率為 5.23%。北美目前佔據非處方藥 (OTC) 市場的主導地位，到 2024 年將達到 42.2%。該地區市場的發展受到消費者對自我藥療的強烈偏好、高昂的醫療保健支出、廣泛的零售供應以及對非處方藥的有利監管支持的推動。

非處方藥 (OTC)，也稱為非處方藥，無需處方或尋求醫療保健專業人員的治療即可使用。它們安全有效，有助於治療疼痛、咳嗽、感冒、腹瀉、便秘、痤瘡以及控制復發性偏頭痛和過敏。目前，它們在全球各地的藥局、便利商店、超市和加油站均有販售。

非處方藥（OTC）市場趨勢：

越來越多的人使用非處方藥治療輕微疾病是推動市場成長的關鍵因素之一。除此之外，非處方藥，如制酸劑、組織胺-2（H2）阻斷劑和質子幫浦抑制劑（PPI），可用於緩解和預防胃灼熱或酸性消化不良。此外，由於冠狀病毒病（COVID-19）的爆發，人們對自我保健重要性的認知有所提高。這反過來又增加了營養補充劑的銷售量並增強了市場成長。此外，主要參與者正在擴大其產品組合，以擴大其消費者群體並增加其地理影響力。再加上監管機構擴大批准將處方藥轉換為非處方藥，這對市場產生了積極的影響。除此之外，由於醫療成本的增加，目前選擇非處方藥而不是諮詢醫生的人數正在增加。此外，自我藥療實踐有助於控制慢性疾病，減少曠工，並避免在輕微疾病期間耗盡稀缺的醫療資源。其他一些因素，例如全球老年人口的增加、分銷管道的快速擴張以及製藥行業的顯著成長，正在推動整體銷售和盈利能力的成長。

本報告回答的關鍵問題

  • 非處方藥（OTC）市場有多大？非處方藥（OTC）市場的未來前景如何？
  • 推動非處方藥（OTC）市場的關鍵因素有哪些？
  • 哪個地區佔據非處方藥（OTC）市場的最大佔有率？
  • 哪些是全球非處方藥（OTC）市場的領導公司？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球非處方藥（OTC）市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品類型

  • 咳嗽、感冒和流感產品
  • 止痛藥
  • 皮膚科產品
  • 胃腸產品
  • 維生素、礦物質和補充劑（VMS）
  • 減肥/膳食產品
  • 眼科產品
  • 助眠產品
  • 其他

第7章：市場區隔：依行政途徑

  • 口服
  • 腸外
  • 外用
  • 其他

第8章：市場區隔：按劑型

  • 片劑和膠囊
  • 液體
  • 軟膏
  • 其他

第9章：市場區隔：按配銷通路

  • 醫院藥房
  • 零售藥局
  • 網路藥局
  • 其他

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Alkem Laboratories Limited
    • Bayer AG
    • Daiichi Sankyo Company Limited
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Novartis AG
    • Perrigo Company plc
    • Pfizer Inc.
    • Piramal Enterprises Ltd.
    • Reckitt Benckiser Group PLC
    • Sanofi SA
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112025A5189

The global over the counter (OTC) drugs market size was valued at USD 178.00 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 288.29 Billion by 2033, exhibiting a CAGR of 5.23% from 2025-2033. North America currently dominates the over the counter (OTC) drugs market share at 42.2% in 2024. The market in the region is driven by strong consumer preference for self-medication, high healthcare expenditures, widespread retail availability, and favorable regulatory support for non-prescription medications.

Over the counter (OTC) drugs, also known as non-prescription drugs, can be used without a prescription or the need for seeking treatment by a healthcare professional. They are safe and effective and help cure pain, cough and cold, diarrhea, constipation, acne and manage recurring migraines and allergies. They are currently available in pharmacies, convenience stores, supermarkets and gas stations across the globe.

Over The Counter (OTC) Drugs Market Trends:

The increasing utilization of OTC drugs to treat minor ailments among individuals represents one of the key factors bolstering the market growth. Besides this, OTC medications, such as antacids, histamine-2 (H2) blockers, and proton pump inhibitors (PPIs), are used to relieve and prevent heartburn or acid indigestion. In addition, due to the coronavirus disease (COVID-19) outbreak, there is a rise in awareness among individuals about the importance of self-care. This, in turn, is increasing the sales of nutritional supplements and strengthening the market growth. Moreover, key players are expanding their product portfolio to widen their consumer base and increase their geographical presence. This, coupled with the increasing approvals from regulatory bodies for switching prescription drugs to OTC drugs, is positively influencing the market. Apart from this, there is currently an increase in the number of people opting for OTC drugs rather than consulting physicians on account of increasing healthcare costs. Furthermore, self-medication practices can assist in controlling chronic diseases, reducing absenteeism from work, and saving scarce medical resources from being exhausted during minor conditions. Some of the other factors, such as the rising geriatric population worldwide, rapid expansion of distribution channels, and significant growth in the pharmaceutical industry, are driving the overall sales and profitability.

Key Market Segmentation:

Breakup by Product Type:

  • Cough, Cold and Flu Products
  • Analgesics
  • Dermatology Products
  • Gastrointestinal Products
  • Vitamins, Minerals and Supplements (VMS)
  • Weight-loss/Dietary Products
  • Ophthalmic Products
  • Sleeping Aids
  • Others

Breakup by Route of Administration:

  • Oral
  • Parenteral
  • Topical
  • Others

Breakup by Dosage Form:

  • Tablets and Capsules
  • Liquids
  • Ointments
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Alkem Laboratories Limited, Bayer AG, Daiichi Sankyo Company Limited, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Perrigo Company plc, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

  • 1.How big is the over the counter (OTC) drugs market?
  • 2.What is the future outlook of the over the counter (OTC) drugs market?
  • 3.What are the key factors driving the over the counter (OTC) drugs market?
  • 4.Which region accounts for the largest over the counter (OTC) drugs market share?
  • 5.Which are the leading companies in the global over the counter (OTC) drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Over The Counter (OTC) Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Cough, Cold and Flu Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Analgesics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Dermatology Products
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Gastrointestinal Products
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Vitamins, Minerals and Supplements (VMS)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Weight-loss/Dietary Products
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Ophthalmic Products
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Sleeping Aids
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast
  • 6.9 Others
    • 6.9.1 Market Trends
    • 6.9.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Parenteral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Topical
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Dosage Form

  • 8.1 Tablets and Capsules
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Liquids
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ointments
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Alkem Laboratories Limited
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Daiichi Sankyo Company Limited
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Dr. Reddy's Laboratories Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 GlaxoSmithKline plc
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Novartis AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Perrigo Company plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Piramal Enterprises Ltd.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Reckitt Benckiser Group PLC
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Sanofi S.A.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Sun Pharmaceutical Industries Ltd.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Teva Pharmaceutical Industries Ltd.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Over The Counter Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Over The Counter Drugs Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Over The Counter Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Over The Counter Drugs Market: Breakup by Product Type (in %), 2024
  • Figure 5: Global: Over The Counter Drugs Market: Breakup by Route of Administration (in %), 2024
  • Figure 6: Global: Over The Counter Drugs Market: Breakup by Dosage Form (in %), 2024
  • Figure 7: Global: Over The Counter Drugs Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Over The Counter Drugs Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Over The Counter Drugs (Cough, Cold and Flu Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Over The Counter Drugs (Cough, Cold and Flu Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Over The Counter Drugs (Analgesics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Over The Counter Drugs (Analgesics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Over The Counter Drugs (Dermatology Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Over The Counter Drugs (Dermatology Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Over The Counter Drugs (Gastrointestinal Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Over The Counter Drugs (Gastrointestinal Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Over The Counter Drugs (Vitamins, Minerals and Supplements (VMS)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Over The Counter Drugs (Vitamins, Minerals and Supplements (VMS)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Over The Counter Drugs (Weight-loss/Dietary Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Over The Counter Drugs (Weight-loss/Dietary Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Over The Counter Drugs (Ophthalmic Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Over The Counter Drugs (Ophthalmic Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Over The Counter Drugs (Sleeping Aids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Over The Counter Drugs (Sleeping Aids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Over The Counter Drugs (Other Product Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Over The Counter Drugs (Other Product Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Over The Counter Drugs (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Over The Counter Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Over The Counter Drugs (Parenteral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Over The Counter Drugs (Parenteral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Over The Counter Drugs (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Over The Counter Drugs (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Over The Counter Drugs (Other Route of Administrations) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Over The Counter Drugs (Other Route of Administrations) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Over The Counter Drugs (Tablets and Capsules) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Over The Counter Drugs (Tablets and Capsules) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Over The Counter Drugs (Liquids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Over The Counter Drugs (Liquids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Over The Counter Drugs (Ointments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Over The Counter Drugs (Ointments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Over The Counter Drugs (Other Dosage Forms) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Over The Counter Drugs (Other Dosage Forms) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Global: Over The Counter Drugs (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Global: Over The Counter Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Global: Over The Counter Drugs (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Global: Over The Counter Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Global: Over The Counter Drugs (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Global: Over The Counter Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Global: Over The Counter Drugs (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Global: Over The Counter Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: North America: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: North America: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: United States: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: United States: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Canada: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Canada: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Asia-Pacific: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Asia-Pacific: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: China: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: China: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Japan: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Japan: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: India: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: India: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: South Korea: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: South Korea: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Australia: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Australia: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Indonesia: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Indonesia: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Others: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Europe: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Europe: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Germany: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Germany: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: France: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: France: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: United Kingdom: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: United Kingdom: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Italy: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Italy: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Spain: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Spain: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Russia: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Russia: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Others: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Latin America: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Latin America: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Brazil: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 92: Brazil: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 93: Mexico: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 94: Mexico: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 95: Others: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 96: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 97: Middle East and Africa: Over The Counter Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 98: Middle East and Africa: Over The Counter Drugs Market: Breakup by Country (in %), 2024
  • Figure 99: Middle East and Africa: Over The Counter Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 100: Global: Over The Counter Drugs Industry: SWOT Analysis
  • Figure 101: Global: Over The Counter Drugs Industry: Value Chain Analysis
  • Figure 102: Global: Over The Counter Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Over The Counter Drugs Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Over The Counter Drugs Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Over The Counter Drugs Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 4: Global: Over The Counter Drugs Market Forecast: Breakup by Dosage Form (in Million USD), 2025-2033
  • Table 5: Global: Over The Counter Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Over The Counter Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Over The Counter Drugs Market: Competitive Structure
  • Table 8: Global: Over The Counter Drugs Market: Key Players